MarketsandMarkets

Biogene Confex 2022

16th - 17th June 2022

Double Tree by Hilton San Diego- Mission Valley

40+

Speaker

10+

Networking Hours

10+

Sessions

300+

Attendees

MarketsandMarkets is providing a platform for pharmaceutical, biotechnology professionals and technology providers to come together at the BioGeNe 2022 Confex on the 16th - 17th June 2022 in San Diego-USA to discuss advancements and solutions to the most critical challenges in the Biomarker, Microbiome and Genome engineering areas.

With growing pressures of increasing success rates for FDA approved biomarkers as well as companion diagnostics tests has seen an outgrowth in drug discovery companies to invest in novel strategies for biomarker discovery. The industry of genome editing has witnessed some great breakthroughs during a year in the areas like genome writing, base editing and specific progression in the field of therapeutics through the Car-T cells and immunotherapy.  With the increasing focus on the development of human microbiome therapies and probiotics product &drug development various small innovative players are operating in the market.

The three conferences which are going to be a part of Biogene Confex 2022 are, 7th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference and 4th Annual MarketsandMarkets Next-Gen Microbiome and Probiotics Conference 

CO-LOCATED CONFERENCES

7th Annual MarketsandMarkets Biomarker and Companion Diagnostics Conference
4th Annual MarketsandMarkets  Next-Gen Microbiome and Probiotics Conference

WHAT TO EXPECT

  • Clinical biomarker identification and qualification
  • Biomarkers and personalized medicine
  • Assay development and validation
  • NGS and novel technologies in biomarker discovery
  • Commercialization of biomarkers in therapeutic and CDx applications
  • Base editing through genome editing tools
  • Precision gene editing
  • Diagnosis of therapy through CRISPR
  • Single cell base editing
  • Car-T cell therapy Applications of Nanopore sequencing in healthcare
  • Spatial sequencing and its applications
  • Deep Sequencing with NGS

  • Experts from academia and industry presenting their current work in Biomarkers
  • Latest updates on regulatory guidelines and approvals
  • Case studies from experts who have successfully created and developed a biomarker
  • Facilitated networking sessions to ensure quality interactions
  • One on one query handling by biomarker experts
  • Opportunity to develop long-lasting business relationships and networking opportunities with senior peers.

From Pharmaceutical and Bio-pharmaceutical companies:

Chief Scientific Officers/ Chief Executive Officer’s/Senior Scientists/ Principal Scientists/CMO/ CTO/ Director/ VP/ Head/ Manager/ Lead Architects/ Lead Engineers/ Group leaders/ Clinicians/ Practitioners (Physicians)/ Professors/ Project Leaders Heads.

From Universities and Research institutes:

Professors/ Assistant Professors/ Researchers/ Scientists/ Principal Scientists

CONFERENCE SPEAKERS

ADVISORS

John Rossi

John Rossi

Vice President, Head, Translational Medicine, , Syncopation Lifesciences

 Julius Goepp

Julius Goepp

CEO, Evimero

 Emily Stein

Emily Stein

CEO, Primal Health Inc.

Yug Varma

Yug Varma

CEO, Phi Therapeutics

 Nicole M. Scott

Nicole M. Scott

CEO and Founder, Cybele Microbiome

Matt Davis

Matt Davis

Director, Molecular Biology & Sequencing, Gritstone Oncology, Inc.

Miten Jain

Miten Jain

Assistant Research Scientist, University of California Santa Cruz

Matteo D’Antonio

Matteo D’Antonio

Assistant Professor, University of California, San Diego

SPEAKERS

Carl Saab

Carl Saab

Professor, Innovation Lead Digital Health, Cleveland Clinic

Santhoshi Krishnan

Santhoshi Krishnan

Senior Research Student, University of Michigan

Joshua Campbell

Joshua Campbell

Professor, Boston University School of Medicine

Arun Devotta

Arun Devotta

Associate Research Scientist, New York University

 Brittany Rife

Brittany Rife

University of Florida, Research Assistant Scientist

 Manoj Bhasin

Manoj Bhasin

Director, Bioinformatics and Systems Biology Shared Resource, Winship Cancer Institute

Kelly A Frazer

Kelly A Frazer

Director, Institute for Genomic Medicine, University of California, San Diego

Maya Ivanjesku

Maya Ivanjesku

Chief Scientific Officer, M2B Pharma

Denise Kelly

Denise Kelly

Investment Advisor, Seventure

Ross Youngs

Ross Youngs

CEO & Founder, Biosortia Pharmaceuticals

 Julie Schwedock

Julie Schwedock

Associate Director, Microbial Development Team, Takeda Pharmaceuticals

Naveen Babbar

Naveen Babbar

Executive Director, Precision Medicine Leader, Novartis

Yisrael Katz

Yisrael Katz

Senior Medical Director , Viracta Therapeutics, Inc.

 Paul Kassner

Paul Kassner

Senior Vice President, Quantitative & Computational Biology , RAPT Therapeutics

John Rossi

John Rossi

Vice President, Head, Translational Medicine, , Syncopation Lifesciences

Partha Das

Partha Das

Medical Director, Oncology CDx and Biomarkers, Amgen

Francie Barron

Francie Barron

Vice President, Innovation Partnerships, Cardea Bio

Christos Patriotis

Christos Patriotis

Program Director, Breast and GYN Cancers, and Bioinformatics, NCI, NIH

Zheng Feng

Zheng Feng

Head, Molecular Biomarkers & Genomics, EMD Serono

 Hedieh Saffari

Hedieh Saffari

Biomarker Clinical Assay Lead, Manager, Pfizer

Mike Baratta

Mike Baratta

Scientific Director, Translational Biomarker Research , Takeda

Matteo D’Antonio

Matteo D’Antonio

Assistant Professor, University of California, San Diego

Miten Jain

Miten Jain

Assistant Research Scientist, University of California Santa Cruz

Matt Davis

Matt Davis

Director, Molecular Biology & Sequencing, Gritstone Oncology, Inc.

 Nicole M. Scott

Nicole M. Scott

CEO and Founder, Cybele Microbiome

Yug Varma

Yug Varma

CEO, Phi Therapeutics

 Emily Stein

Emily Stein

CEO, Primal Health Inc.

 Julius Goepp

Julius Goepp

CEO, Evimero

ENQUIRE NOW

SPONSORS

LOCATION

Venue

Double Tree by Hilton San Diego- Mission Valley

PAST EVENT GALLERY